Ventas, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Follow the Ventas, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Real Estate sector, Ventas, Inc. has logged 495 reports. Market capitalisation: €46.6bn. The latest transaction was disclosed on 4 August 2026 (Attribution). Among the most active insiders: CAFARO DEBRA A. All data is openly available.
Analyst consensus: bullish or bearish? Analysts rate Ventas, Inc. Buy (bullish), based on 22 analysts. Average price target: US$99.68.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,243 of 29,055 companies
FCF yld 2.1%
Earn yld 0.5%
EV/EBITDA 26.6x
ROE 2.0%
Gross mgn 41%
Net mgn 4.3%
Debt/EBITDA 5.8x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 August 2026
All Executives495 Thresholds0 Prospectus0 Other0
Declarations 495 total
◆ EVP OM&R-Ventas/Pres&CEO-LHS · Executives · 1 Aug 2026
10,694 shares @ US$93.51 Common Stock SEC:0001952659-26-000007:0
◆ EVP OM&R-Ventas/Pres&CEO-LHS · Executives · 1 Aug 2026
4,314 shares @ US$93.51 Common Stock SEC:0001952659-26-000007:1
◆ Director · Executives · 16 Jul 2026
71.615 shares @ US$95.04 0.0000% mcap 0.5% of flow Common Stock SEC:0001529329-26-000020:1
◆ Director · Executives · 16 Jul 2026
71.615 shares @ US$95.04 0.0000% mcap 0.4% of flow Common Stock SEC:0001841752-26-000019:1
◆ Director · Executives · 16 Jul 2026
71.615 shares @ US$95.04 0.0000% mcap 0.7% of flow Common Stock SEC:0001619369-26-000008:0
◆ Director · Executives · 16 Jul 2026
71.615 shares @ US$95.04 0.0000% mcap 0.6% of flow Common Stock SEC:0001209170-26-000014:0
◆ Director · Executives · 16 Jul 2026
209.667 shares @ US$95.04 0.0000% mcap 0.9% of flow Common Stock SEC:0001203367-26-000024:0
◆ Director · Executives · 16 Jul 2026
71.615 shares @ US$95.04 0.0000% mcap 0.3% of flow Common Stock SEC:0001203367-26-000024:1
◆ Director · Executives · 16 Jul 2026
173.886 shares @ US$95.04 0.0000% mcap 0.8% of flow Common Stock SEC:0001676558-26-000014:0
◆ Director · Executives · 16 Jul 2026
71.615 shares @ US$95.04 0.0000% mcap 0.7% of flow Common Stock SEC:0001356681-26-000010:0
◆ Director · Executives · 16 Jul 2026
48.513 shares @ US$95.04 0.0000% mcap 0.7% of flow Common Stock SEC:0002014328-26-000008:0
◆ Director · Executives · 16 Jul 2026
47.088 shares @ US$95.04 0.0000% mcap 0.3% of flow Common Stock SEC:0001529329-26-000020:0
◆ Director · Executives · 16 Jul 2026
56.195 shares @ US$95.04 0.0000% mcap 0.3% of flow Common Stock SEC:0001841752-26-000019:0
▲ Director · Executives · 3 Jun 2026
2,500 shares @ US$78.81 0.0004% mcap 14.3% of flow Common Stock SEC:0001209170-26-000012:0
Canonical exit: 1 Sept 2026 (T+90) ◆ Director · Executives · 13 May 2026
2,047 shares @ US$90.35 0.0004% mcap 21.8% of flow Common Stock SEC:0001676558-26-000010:0
◆ Director · Executives · 13 May 2026
2,047 shares @ US$90.35 0.0004% mcap 50.0% of flow Common Stock SEC:0002014328-26-000006:0
◆ Director · Executives · 13 May 2026
2,047 shares @ US$90.35 0.0004% mcap 50.0% of flow Common Stock SEC:0001529329-26-000016:0
◆ Director · Executives · 13 May 2026
2,047 shares @ US$90.35 0.0004% mcap 32.8% of flow Common Stock SEC:0001841752-26-000013:0
◆ Director · Executives · 13 May 2026
2,047 shares @ US$90.35 0.0004% mcap 32.8% of flow Common Stock SEC:0001569926-26-000012:0
◆ Director · Executives · 13 May 2026
2,047 shares @ US$90.35 0.0004% mcap 32.8% of flow Common Stock SEC:0001356681-26-000008:0
◆ Director · Executives · 13 May 2026
2,047 shares @ US$90.35 0.0004% mcap 50.0% of flow Common Stock SEC:0001042733-26-000002:0
◆ Director · Executives · 13 May 2026
2,047 shares @ US$90.35 0.0004% mcap 10.7% of flow Common Stock SEC:0001203367-26-000014:0
◆ Director · Executives · 13 May 2026
2,047 shares @ US$90.35 0.0004% mcap 32.8% of flow Common Stock SEC:0001202432-26-000002:0
◆ Director · Executives · 13 May 2026
2,047 shares @ US$90.35 0.0004% mcap 30.9% of flow Common Stock SEC:0001209170-26-000006:0
◆ Director · Executives · 13 May 2026
2,047 shares @ US$90.35 0.0004% mcap 32.8% of flow Common Stock SEC:0001619369-26-000006:0
25 of 495 declarations
Load more (470 remaining) 关于 Ventas, Inc. Ventas, Inc. (NYSE: VTR) 是一家在美国上市的医疗保健房地产投资信托公司,也是标准普尔500指数的成分股。公司总部位于伊利诺伊州芝加哥,成立于1983年,现已发展成为北美最知名的医疗保健和老龄化相关房地产所有者之一。其投资组合涵盖老年人社区、门诊医疗大楼、研究中心以及提供重症护理的专业设施。Ventas通过三个运营部门报告:SHOP(老年人住房运营组合)、OM&R(门诊医疗和研究)以及NNN(三净租赁物业)。([s203.q4cdn.com](https://s203.q4cdn.com/581756553/files/doc_financials/2025/q4/Ventas-Reports_2025_Fourth_Quarter_Results.pdf))
从战略角度来看,Ventas围绕着长期人口需求而建立。公司强调美国人口老龄化、对更多老年人住房的需求以及对门诊护理和医疗研究基础设施日益增长的需求。其商业模式结合了直接所有权、运营商合作关系和长期租赁结构,使公司能够同时追求运营上行空间和收入持久性。Ventas还强调其数据驱动的Ventas OITM平台及其强大的资本基础,作为投资组合管理和资本配置的差异化工具。([s203.q4cdn.com](https://s203.q4cdn.com/581756553/files/doc_financials/2025/q4/Ventas-Reports_2025_Fourth_Quarter_Results.pdf))
Ventas并非传统的医疗保健运营商;它主要是一家房地产所有者和资本提供者。在SHOP部门,它拥有老年人社区并聘请第三方运营商进行管理。在OM&R部门,它主要收购、拥有、开发、租赁和管理门诊医疗大楼和研究中心。在NNN部门,它拥有医疗保健设施,如老年人住房、专业护理设施、长期急性护理设施、住院康复设施以及其他根据三净或绝对净租赁协议租赁的专业资产。这种组合使公司能够接触到医疗保健房地产价值链的多个部分,同时将核心理念集中在与老龄化相关的需求上。([app.edgar.tools](https://app.edgar.tools/companies/VTR/disclosures/segments?utm_source=openai))
竞争地位依然强劲。Ventas称自己是最大的老年人住房所有者之一,在美国、加拿大和英国拥有广泛的投资组合。公司近期披露的信息还显示,截至2025年末,其投资组合约有1,409处物业,突显了其规模。对于法国、比利时和瑞士的投资者而言,这种规模、经常性租金敞口和人口结构顺风的结合,使得Ventas成为一家值得关注的医疗保健房地产投资信托基金,而非纯粹的房地产公司。([s203.q4cdn.com](https://s203.q4cdn.com/581756553/files/doc_financials/2025/q4/Ventas-Reports_2025_Fourth_Quarter_Results.pdf))
近期发展强化了增长叙事。2025年,Ventas以2.3 billion美元收购了52个老年人社区,并在2026年1月和2月以842.2 million美元收购了另外26个老年人社区。公司还在2026年初改善了杠杆指标,并于2026年5月宣布每股季度股息为0.52美元。总而言之,这些更新表明管理团队正在积极寻求外部增长,同时保持纪律的资产负债表,并明确专注于老年人住房这一其最大且发展最快的业务引擎。([s203.q4cdn.com](https://s203.q4cdn.com/581756553/files/doc_financials/2025/ar/2025_VTR_AnnualReport.pdf))